24HourWire
News from all angles
MedPage Today
Center
FDA Warns of New Blood Cancers With Sarcoma, Lymphoma Drug
(MedPage Today) -- The FDA on Monday alerted clinicians about the risk of new primary hematologic malignancies in patients treated with tazemetostat (Tazverik), a sarcoma and lymphoma drug now being …